Trials / Sponsors / Guru Sonpavde
Guru Sonpavde
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy Advanced Urothelial Carcinoma | Phase 2 | 2026-02-01 |
| Withdrawn | Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer | Phase 2 | 2017-05-23 |